Episode 206: Graft-Versus-Host Disease: Biomarkers and Beyond

“Biomarkers give us information not only to diagnose a patient, but also to see whether a patient is going to have GVHD in the near future, whether a patient is going to respond to the treatment we’ll give, and what would be the overall outcome and survival.” ONS member Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP®, research nurse practitioner at MD Anderson Cancer Center in Houston, TX, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about managing acute and chronic graft-versus-host disease (GVHD) and biomarkers for the condition. You can earn free NCPD contact hours by completing the evaluation linked in the episode notes.   

Music Credit: "Fireflies and Stardust" by Kevin MacLeod  

Licensed under Creative Commons by Attribution 3.0 

Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by May 6, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation. 

Episode Notes 

Check out these resources from today’s episode: 

To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  

To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org

Listen on:

Listen on iTunes, Listen on Google Podcasts, Listen on Stitcher, Listen on Spotify, Listen on Amazon Music

ONS Podcasts

Expand your knowledge by listening to the Oncology Nursing Podcast.

View All Podcasts